Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Leukemia is a cancer of the blood. In leukemia, normal blood cells are transformed in ways that lead to high counts of white blood cells.
Myeloid leukemia develops from cells that give rise to white blood cells called granulocytes and monocytes. The main function of granulocytes is to destroy bacteria.
The term “chronic” means that the disease progresses slowly over a period of time, unlike acute leukemias which develop quickly. Chronic myeloid leukemia (CML) is considered a pre-leukemic condition. CML cells have genetic abnormalities that lead to excessive growth of blood cells. But it does not cause the same complications seen in other related fast-growing leukemias like acute myeloid leukemia.
The Stanford Medicine Online Second Opinion program offers you easy access to our world-class doctors. It’s all done remotely and you don’t have to visit our hospital or one of our clinics for this service. You don’t even need to leave home!
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.